- Investing Ideas
- /
- Global Strong Balance Sheet Stocks
Global Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3,948 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIXAnixa Biosciences | US$3.10 | -9.1% | -26.4% | US$93.4m | US$11.00 | PS182.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
| CYTRCytRx | US$0.48 | -20.0% | -80.2% | US$18.6m | n/a | PB1.9x | n/a | n/a | Pharmaceuticals & Biotech | ||
| REFRResearch Frontiers | US$1.52 | -7.3% | -63.7% | US$48.1m | n/a | PS40.7x | n/a | n/a | Tech | ||
| USEGU.S. Energy | US$3.21 | -13.2% | -29.5% | US$78.9m | n/a | PS15.6x | n/a | n/a | Energy | ||
| BYFCBroadway Financial | US$2.06 | -12.3% | -4.6% | US$147.8m | n/a | PB1.1x | n/a | 0% | Banks | ||
| GMEGameStop | US$106.36 | -8.8% | 63.6% | US$8.1b | US$34.00 | PS1.4x | E100.6% | 0% | Retail | ||
| MACKMerrimack Pharmaceuticals | US$4.53 | -2.4% | -40.1% | US$60.7m | n/a | PB4.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
| VBLTVascular Biogenics | US$1.35 | -20.6% | -49.8% | US$93.6m | US$5.50 | PS120.4x | E50.6% | n/a | Pharmaceuticals & Biotech | ||
| PPSIPioneer Power Solutions | US$6.02 | -25.6% | -33.1% | US$58.0m | n/a | PS2.9x | n/a | n/a | Capital Goods | ||
| MCHXMarchex | US$2.44 | -5.4% | -10.6% | US$98.8m | US$4.00 | PS1.9x | E-43.3% | 0% | Media | ||
| LTBRLightbridge | US$5.67 | -12.0% | -17.1% | US$43.3m | n/a | PB2.8x | n/a | n/a | Energy | ||
| CHNRChina Natural Resources | US$0.91 | -7.1% | -46.8% | US$37.3m | n/a | PB2.3x | n/a | n/a | Materials | ||
| NVRONevro | US$85.86 | -6.7% | -51.2% | US$3.0b | US$109.00 | PS7.6x | E37.9% | n/a | Healthcare | ||
| DRNADicerna Pharmaceuticals | US$38.22 | 0.6% | 72.9% | US$3.0b | US$36.43 | PS15.5x | E-8.1% | n/a | Pharmaceuticals & Biotech | ||
| CTMXCytomX Therapeutics | US$4.29 | 8.6% | -35.5% | US$279.9m | US$12.25 | PS4.2x | E-14.9% | n/a | Pharmaceuticals & Biotech | ||
| ATXSAstria Therapeutics | US$4.83 | 2.1% | -70.5% | US$62.8m | US$22.80 | PB1.8x | E29.6% | n/a | Pharmaceuticals & Biotech | ||
| ATGNAltigen Communications | US$1.15 | -8.0% | -56.6% | US$27.4m | n/a | PS2.5x | n/a | n/a | Tech | ||
| GIGAGiga-tronics | US$2.76 | -3.2% | -30.5% | US$8.8m | n/a | PB3.5x | n/a | n/a | Capital Goods | ||
| SLNC.FSilence Therapeutics | US$7.09 | -11.2% | -2.7% | US$636.6m | n/a | PS41.4x | E-30.0% | n/a | Pharmaceuticals & Biotech | ||
| GTBPGT Biopharma | US$2.65 | -10.8% | -64.6% | US$80.8m | US$25.33 | PB2.5x | E-9.8% | n/a | Pharmaceuticals & Biotech | ||
| ENZNEnzon Pharmaceuticals | US$0.35 | -1.4% | -18.6% | US$26.0m | n/a | PS36.8x | n/a | n/a | Pharmaceuticals & Biotech | ||
| SLNHSoluna Holdings | US$8.28 | -23.3% | 86.1% | US$108.7m | n/a | PS8.6x | n/a | n/a | Tech | ||
| PEYEPrecision Optics Corporation | US$2.46 | 9.3% | 52.8% | US$41.2m | n/a | PS4x | n/a | n/a | Healthcare | ||
| JSDAJones Soda | US$0.56 | -17.2% | 31.6% | US$37.7m | n/a | PS2.6x | n/a | n/a | Food, Beverage & Tobacco |